Results 81 to 90 of about 313,783 (196)
Introduction: Adhesive capsulitis is idiopathic, progressive, painful, and restricted active and passive shoulder range of motion in patients with normal radiographs.
Puja Sannyashi
doaj +1 more source
Background: Frozen shoulder syndrome is clinically known as adhesive capsulitis, is a painful and debilitating condition causing fibrosis of the glenohumeral joint capsule with a chronic inflammatory response.
Umair Ur Rehman +2 more
doaj
COMPLEX PHYSICAL THERAPY OF PATIENTS WITH ADHESIVE CAPSULITIS
Adhesive capsulitis is predominantly an idiopathic condition and is more common in patients with metabolic disorders. PS contracture can be of varying degrees of severity, depending on the pathology of the PS with which we are dealing.
О. Дорофєєва +6 more
doaj +1 more source
Evaluating the outcome of distal sodium channel block by Chennai cocktail composition in active phase (stage 1) of adhesive capsulitis (frozen shoulder) [PDF]
Background/Aim: The average age range for people with adhesive capsulitis, also referred to as frozen shoulder, is 40-70 years old. Diffuse, severe shoulder pain gradually develops; it usually gets worse at night and causes a progressive loss of range of
Doddabasappa Mruthyunjaya Talak +4 more
doaj +1 more source
Objective: To compare the effect of short wave diathermy to ultra-sonic therapy for decreasing pain and increasing Range of Motion (R.O.M) in Adhesive Capsulitis.
Nazia Nazar, Rana Muhammad Tahir
doaj
Background Measurements of range of motion play a key role in shoulder research. The purpose of this study is to investigate intra-observer reproducibility of measurements of active and passive range of motion in patients with adhesive capsulitis ...
Juel Niels +3 more
doaj +1 more source
Background: This prospective study aimed to determine the factors influencing the efficacy of guided intervention-based management of shoulder adhesive capsulitis secondary to breast cancer treatment.
Chandrakant Pilania +4 more
doaj +1 more source
: Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly used for managing type 2 diabetes mellitus (T2DM) and obesity due to their proven metabolic benefits.
William R. Davis, BS +4 more
doaj +1 more source

